{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:24Z","timestamp":1790959284119,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.arcmed.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:25:00Z","timestamp":1565241900000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Vildagliptin and G-CSF Improved Angiogenesis and Survival after Acute Myocardial Infarction"],"prefix":"10.1016","volume":"50","author":[{"given":"Mincai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.devcel.2013.01.009","article-title":"Peripheral nerve-derived CXCL12 and VEGF-A regulate the patterning of arterial vessel branching in developing limb skin","volume":"24","author":"Li","year":"2013","journal-title":"Dev Cell"},{"key":"10.1016\/j.arcmed.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/term.2233","article-title":"Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells","volume":"11","author":"Odent Grigorescu","year":"2017","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.arcmed.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni813","article-title":"G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4","volume":"3","author":"Petit","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/gt.2012.32","article-title":"SDF-1 in myocardial repair","volume":"19","author":"Penn","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.arcmed.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2174\/13816128113199990443","article-title":"Effect of SDF-1 alpha on endogenous mobilized and transplanted stem cells in regeneration after myocardial infarction","volume":"20","author":"Schuh","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.arcmed.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1096\/fj.06-6558com","article-title":"SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction","volume":"21","author":"Zhang","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2019.07.004_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2015.00477","article-title":"Dipeptidyl peptidase-4 regulation of SDF-1\/CXCR4 axis: implications for cardiovascular disease","volume":"6","author":"Zhong","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12933-017-0572-0","article-title":"The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction","volume":"16","author":"Wang","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.2337\/db16-0107","article-title":"Quantification of the contribution of GLP-1 to mediating insulinotropic Effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin (9-39) as a GLP-1 receptor antagonist","volume":"65","author":"Nauck","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bmc.2009.11.047","article-title":"Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus","volume":"18","author":"Zarubaev","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.arcmed.2019.07.004_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1113\/EP085108","article-title":"Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction","volume":"100","author":"Inthachai","year":"2015","journal-title":"Exp Physiol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-10-85","article-title":"Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure","volume":"10","author":"Yin","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/01.CIR.0000138153.02213.22","article-title":"Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium","volume":"110","author":"Wu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2019.07.004_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2337\/db13-0802","article-title":"ITCH deficiency protects from diet-induced obesity","volume":"63","author":"Marino","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2019.07.004_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction","volume":"4","author":"Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.arcmed.2019.07.004_bib16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1096\/fj.05-4763fje","article-title":"G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis","volume":"20","author":"Deindl","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2019.07.004_bib17","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s13277-013-0878-9","article-title":"Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","article-title":"Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.arcmed.2019.07.004_bib19","first-page":"20152147","article-title":"Cardiac regeneration: epicardial mediated repair","volume":"282","author":"Kennedy-Lydon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.arcmed.2019.07.004_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/CIRCRESAHA.111.245589","article-title":"Signaling during epicardium and coronary vessel development","volume":"109","author":"Perez-Pomares","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2019.07.004_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.scr.2014.04.007","article-title":"The epicardium signals the way towards heart regeneration","volume":"13","author":"Masters","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.arcmed.2019.07.004_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cell.2013.07.039","article-title":"Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair","volume":"154","author":"Ellison","year":"2013","journal-title":"Cellule"},{"key":"10.1016\/j.arcmed.2019.07.004_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.stemcr.2017.03.001","article-title":"In\u00a0vitro generation of vascular wall-resident multipotent stem cells of mesenchymal nature from murine induced pluripotent stem cells","volume":"8","author":"Steens","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.arcmed.2019.07.004_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yjmcc.2015.01.024","article-title":"A critical role of Src family kinase in SDF-1\/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart","volume":"81","author":"Cheng","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.109.198929","article-title":"Importance of the SDF-1:CXCR4 axis in myocardial repair","volume":"104","author":"Penn","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2019.07.004_bib26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2019.07.004_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","article-title":"Cardiovascular effects of DPP-4 inhibition: beyond GLP-1","volume":"55","author":"Fadini","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2019.07.004_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature06969","article-title":"A myocardial lineage derives from Tbx18 epicardial cells","volume":"454","author":"Cai","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2019.07.004_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07060","article-title":"Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart","volume":"454","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2019.07.004_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature13839","article-title":"Mesenchymal-endothelial transition contributes to cardiac neovascularization","volume":"514","author":"Ubil","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2019.07.004_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","article-title":"Cardiac stem cell therapy and the promise of heart regeneration","volume":"12","author":"Garbern","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.arcmed.2019.07.004_bib34","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.ijcard.2012.06.052","article-title":"MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis","volume":"167","author":"Lu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arcmed.2019.07.004_bib35","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/STROKEAHA.114.005078","article-title":"Postacute stromal cell-derived factor-1alpha expression promotes neurovascular recovery in ischemic mice","volume":"45","author":"Li","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.arcmed.2019.07.004_bib36","doi-asserted-by":"crossref","first-page":"H455","DOI":"10.1152\/ajpheart.00726.2015","article-title":"Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease","volume":"310","author":"Hou","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844091830701X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844091830701X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:47:41Z","timestamp":1759261661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844091830701X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S018844091830701X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.07.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vildagliptin and G-CSF Improved Angiogenesis and Survival after Acute Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}